1. A case of facial cellulitis caused by group B streptococcus in an extremely low birthweight infant
- Author
-
Yuki Kodama, Naoshi Yamada, Kazuhiko Nakame, Hiroshi Sameshima, Rie Yamashita, Junsuke Muraoka, Masatoki Kaneko, and Marie Higashi
- Subjects
Male ,0301 basic medicine ,Microbiology (medical) ,Pediatrics ,medicine.medical_specialty ,medicine.medical_treatment ,030106 microbiology ,medicine.disease_cause ,Group B ,Streptococcus agalactiae ,Sepsis ,03 medical and health sciences ,0302 clinical medicine ,Pregnancy ,Streptococcal Infections ,medicine ,Birth Weight ,Humans ,Pharmacology (medical) ,030212 general & internal medicine ,reproductive and urinary physiology ,Debridement ,Neonatal sepsis ,Cesarean Section ,Streptococcus ,business.industry ,High mortality ,Infant, Newborn ,Cellulitis ,bacterial infections and mycoses ,medicine.disease ,Infectious Diseases ,Female ,business ,Meningitis - Abstract
Group B streptococcus (GBS) is an important pathogen that causes neonatal sepsis and meningitis, which have high mortality and morbidity. Cellulitis is a rare presentation of late-onset neonatal GBS infection. We report the case of an extremely low birthweight infant with facial cellulitis caused by late-onset GBS infection. A 590-g male neonate was delivered by Cesarean section at 23 gestational weeks due to intrauterine GBS infection. Although he was effectively treated with 2 weeks of antimicrobial therapy for early-onset GBS sepsis, he subsequently developed facial and submandibular cellulitis caused by GBS at 44 days of age. He was treated with debridement and antibiotic therapy, and after 2 months his facial involvement had improved, but cosmetic issues remained. Neonatal GBS infection requires a prompt sepsis workup followed by the initiation of empiric antibiotic therapy. Additionally, lifesaving surgical debridement is sometimes necessary for cellulitis, even in premature infants.
- Published
- 2021